Table 2.
Comorbidities and adverse effects of ovarian cancer and its treatment | Considerations | Actions/strategy |
Comorbidities | ||
Disorders of the thyroid gland (ie, hypothyroidism/hyperthyroidism) | Consider the following complications of disorders of thyroid gland: | |
|
|
|
|
|
|
| ||
|
|
|
| ||
Disorders of gallbladder, biliary tract and pancreas (ie, cholelithiasis) |
|
|
Malignant neoplasms (excluding basal cell carcinoma)* | Consider comorbidities and adverse effects of malignant neoplasm that might interfere with the intervention | |
Adverse effects of ovarian cancer | ||
Ascites (60%) | Consider the following complications of ascites: | |
|
|
|
|
|
|
|
|
|
Adverse effects of chemotherapy and surgery | ||
Abdominal wound |
|
|
| ||
| ||
Consider the following complications of an abdominal wound: | ||
|
|
|
Intestinal stoma |
|
|
| ||
Consider the following complications of an intestinal stoma | ||
|
|
|
(Risk of) lymphoedema in legs |
|
|
| ||
Consider the following complications of lymphoedema in legs: | ||
|
|
|
| ||
Deep vein thrombosis (in leg) |
|
|
Thrombophlebitis |
|
|
| ||
Nervousness/confusion | Consider the following causes of nervousness/confusion | |
|
|
|
|
||
Gastrointestinal symptoms (ie, anorexia, dyspepsia, constipation, taste disorder, dry mouth, mouth ulcers, stomatitis) | Consider the following complications of gastrointestinal symptoms: | |
|
|
|
Melaena |
|
*Patients with a current other malignancy or prior diagnosis (within 5 years) of cancer were excluded from participation in the Physical Activity and Dietary intervention in OVArian cancer study.